- Home
- APLT vs TACT Comparison
APLT vs TACT Comparison
Compare APLT & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- TACT
- Stock Information
- Founded
- APLT 2016
- TACT 1996
- Country
- APLT United States
- TACT United States
- Employees
- APLT N/A
- TACT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- APLT Health Care
- TACT Technology
- Exchange
- APLT Nasdaq
- TACT Nasdaq
- Market Cap
- APLT 44.0M
- TACT 35.7M
- IPO Year
- APLT 2019
- TACT 1996
- Fundamental
- Price
- APLT $0.39
- TACT $3.76
- Analyst Decision
- APLT Buy
- TACT Strong Buy
- Analyst Count
- APLT 7
- TACT 1
- Target Price
- APLT $6.10
- TACT $5.00
- AVG Volume (30 Days)
- APLT 2.5M
- TACT 14.5K
- Earning Date
- APLT 08-06-2025
- TACT 08-07-2025
- Dividend Yield
- APLT N/A
- TACT N/A
- EPS Growth
- APLT N/A
- TACT N/A
- EPS
- APLT N/A
- TACT N/A
- Revenue
- APLT $265,000.00
- TACT $45,750,000.00
- Revenue This Year
- APLT $1,768.13
- TACT $14.81
- Revenue Next Year
- APLT $292.85
- TACT N/A
- P/E Ratio
- APLT N/A
- TACT N/A
- Revenue Growth
- APLT N/A
- TACT N/A
- 52 Week Low
- APLT $0.30
- TACT $3.12
- 52 Week High
- APLT $10.62
- TACT $5.11
- Technical
- Relative Strength Index (RSI)
- APLT 51.68
- TACT 53.49
- Support Level
- APLT $0.32
- TACT $3.49
- Resistance Level
- APLT $0.36
- TACT $3.79
- Average True Range (ATR)
- APLT 0.03
- TACT 0.21
- MACD
- APLT 0.00
- TACT 0.01
- Stochastic Oscillator
- APLT 73.78
- TACT 67.86
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.